comprehensive -WSS

comprehensive

author：entertainment 2025-09-30 07:34:08 - browse：423

Novo Nordisk Denmark — LISELOTTE SABROE/AFP/Getty Images

An oral version of semaglutide, the drug marketed as Ozempic and Wegovy, led to dramatic weight loss in a trial enrolling people with obesity, manufacturer Novo Nordisk said Monday, data that could bolster what is already a blockbuster medicine.

In the study, which enrolled nearly 700 adults classified as having overweight or obesity, patients treated with a daily semaglutide tablet lost 15.1% of their body weight over the course of 17 months, while those on placebo lost 2.4%, Novo Nordisk said. The result is comparable to weekly injections of Wegovy, which in an earlier study led to 14.9% weight loss over the same period of time. In both studies, the most common side effects were gastrointestinal distress, with the majority of cases graded mild or moderate, the company said.

Novo Nordisk said it plans to submit oral semaglutide for U.S. and E.U. approvals later this year. A lower-dose version of the drug is already approved as a treatment for type 2 diabetes under the brand name Rybelsus.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Extensive review finds private equity owners jack up cost of care

WSS

Unique patient identifier: Experts argue the benefits, pitfalls

Readout LOUD: Venture capital, Gilead, and more M&A

A protest over insulin prices is seen as a fight for life

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

340B reform proposal comes out of Senate working group

Medicare Advantage plans can’t deny care with AI, CMS warns

hotspot

comprehensive

leisure time

In Memoriam: Notable people who died in 2023

AstraZeneca stays mum on Medicare drug pricing negotiations

Medicare details structure of new drug price negotiation program

Mystery swirls around US soldier who entered North Korea days ago, officials say

New air purifier tech could be key to improving indoor air quality

Top private equity targets in 2023: cardiology, clinical trials, lasers

Malaria cases in Florida and Texas: Here’s what you need to know

Johnson & Johnson sued for allegedly overpaying for workers' drugs

Peter Hotez and the public health issue of online harassment

Devoted Health’s losses in Medicare Advantage persist

hotspot

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

Unique patient identifier: Experts argue the benefits, pitfalls

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

A protest over insulin prices is seen as a fight for life

Telehealth startups are trying to fill the menopause care vacuum

focus

hotspot

hotspot

Wikipedia